Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
7 hedge funds and large institutions have $2.53M invested in Meihua International Medical Technologies in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
304% more capital invested
Capital invested by funds: $626K → $2.53M (+$1.9M)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
0.07% more ownership
Funds ownership: 0.03% → 0.1% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.48M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$98.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$23.3K |
| 4 |
MG
Marex Group
London,
|
+$4.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$10.2K |
MHUA Hedge Fund Activity: Q3 2024 in Review
7 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q3 2024, worth a combined $2.53M — up 304% from $626K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MHUA positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Anson Funds Management, adding an estimated $1.48M. The largest seller was Renaissance Technologies, cutting an estimated $10.2K.
- 7 institutional investors held Meihua International Medical Technologies (MHUA) as of Q3 2024, up from 6 in Q2 2024.
- Funds reported $2.53M of Meihua International Medical Technologies stock for Q3 2024, up 304% quarter-over-quarter.
- 1 fund opened new Meihua International Medical Technologies positions in Q3 2024 and 0 closed out, a net change of +1 holder.
- The largest Meihua International Medical Technologies buyer in Q3 2024 was Anson Funds Management, an estimated $1.48M added.
- The largest Meihua International Medical Technologies seller in Q3 2024 was Renaissance Technologies, an estimated $10.2K sold.
Based on aggregated 13F filings for Q3 2024.